7.44
0.39 (5.53%)
| Previous Close | 7.05 |
| Open | 7.18 |
| Volume | 70,889 |
| Avg. Volume (3M) | 87,689 |
| Market Cap | 67,078,184 |
| Price / Sales | 1.73 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2026 |
| Profit Margin | -46.24% |
| Operating Margin (TTM) | -56.88% |
| Diluted EPS (TTM) | -1.53 |
| Quarterly Revenue Growth (YOY) | 23.40% |
| Total Debt/Equity (MRQ) | 95.85% |
| Current Ratio (MRQ) | 1.52 |
| Operating Cash Flow (TTM) | -8.74 M |
| Levered Free Cash Flow (TTM) | -5.06 M |
| Return on Assets (TTM) | -50.68% |
| Return on Equity (TTM) | -276.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | electroCore, Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.3 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | -2.4 |
| Macro Environment | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.78 |
Select this tab to load the latest available analysis.
|
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 29.79% |
| % Held by Institutions | 18.52% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Jaffetilchin Investment Partners, Llc | 30 Jun 2026 | 59,954 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |